Cargando…

Hepatitis B x antigen (HBx) is an important therapeutic target in the pathogenesis of hepatocellular carcinoma

Hepatitis B virus (HBV) is a human pathogen that has infected an estimated two billion people worldwide. Despite the availability of highly efficacious vaccines, universal screening of the blood supply for virus, and potent direct acting anti-viral drugs, there are more than 250 million carriers of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Medhat, Arvin, Arzumanyan, Alla, Feitelson, Mark A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2021
Materias:	Research Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629409/ https://www.ncbi.nlm.nih.gov/pubmed/34853663 http://dx.doi.org/10.18632/oncotarget.28077

Ejemplares similares

Hepatitis B x (HBx) as a Component of a Functional Cure for Chronic Hepatitis B
por: Feitelson, Mark A., et al.
Publicado: (2022)

Epigenetic repression of E-cadherin expression by Hepatitis B virus x Antigen (HBx) in liver cancer
por: Arzumanyan, Alla, et al.
Publicado: (2011)

Short-chain fatty acids in cancer pathogenesis
por: Feitelson, Mark A., et al.
Publicado: (2023)

Short chain fatty acids delay the development of hepatocellular carcinoma in HBx transgenic mice
por: McBrearty, Noreen, et al.
Publicado: (2021)

HBx Gene Mutations in Hepatitis B Virus and Hepatocellular Carcinoma
por: Mathew M, Anumol, et al.
Publicado: (2014)

Relevance of HBx for Hepatitis B Virus-Associated Pathogenesis
por: Schollmeier, Anja, et al.
Publicado: (2023)

Editorial: Microbiome metabolites in health and disease
por: Canfora, Emanuel E., et al.
Publicado: (2023)

Utilizing Experimental Mouse Model to Identify Effectors of Hepatocellular Carcinoma Induced by HBx Antigen
por: Yang, Ming-Hui, et al.
Publicado: (2020)

Transcriptomic identification of HBx-associated hub genes in hepatocellular carcinoma
por: Ni, Zhengzhong, et al.
Publicado: (2021)

Prognostic significance of catalase expression and its regulatory effects on hepatitis B virus X protein (HBx) in HBV-related advanced hepatocellular carcinomas
por: Cho, Mi-Young, et al.
Publicado: (2014)

HBx‐mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasis
por: Chen, Shi‐Lu, et al.
Publicado: (2017)

Mechanism of HBx carcinogenesis interaction with non-coding RNA in hepatocellular carcinoma
por: Wang, Zhuoran, et al.
Publicado: (2023)

The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways
por: Sartorius, Kurt, et al.
Publicado: (2020)

Hepatitis B Viral Protein HBx and the Molecular Mechanisms Modulating the Hallmarks of Hepatocellular Carcinoma: A Comprehensive Review
por: Sivasudhan, Enakshi, et al.
Publicado: (2022)

Deubiquitylation of hepatitis B virus X protein (HBx) by ubiquitin-specific peptidase 15 (USP15) increases HBx stability and its transactivation activity
por: Su, Zhi-Jun, et al.
Publicado: (2017)

Hepatitis B Virus Oncoprotein HBx Is Not an ATPase
por: Langton, Michelle, et al.
Publicado: (2020)

In Silico Molecular Docking and Simulation Studies of Protein HBx Involved in the Pathogenesis of Hepatitis B Virus-HBV
por: Shaikh, Ibrahim Ahmed, et al.
Publicado: (2022)

Hepatitis B Virus HBx Activates Notch Signaling via Delta-Like 4/Notch1 in Hepatocellular Carcinoma
por: Kongkavitoon, Pornrat, et al.
Publicado: (2016)

The Viral Oncoprotein HBx of Hepatitis B virus Promotes the Growth of Hepatocellular Carcinoma through Cooperating with the Cellular Oncoprotein RMP
por: Wang, Qi, et al.
Publicado: (2014)

The therapeutic importance of acid-base balance
por: Quade, Bianca N., et al.
Publicado: (2021)

Role of miR-148a in Hepatitis B Associated Hepatocellular Carcinoma
por: Yuan, Ke, et al.
Publicado: (2012)

Regulatory T-cells promote hepatitis B virus infection and hepatocellular carcinoma progression
por: Li, Wei, et al.
Publicado: (2016)

Hepatitis B Virus X Protein (HBx) Suppresses Transcription Factor EB (TFEB) Resulting in Stabilization of Integrin Beta 1 (ITGB1) in Hepatocellular Carcinoma Cells
por: Zhang, Chunyan, et al.
Publicado: (2021)

HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3
por: Chen, Jhen-Yu, et al.
Publicado: (2015)

HBx mediated Increase of SIRT1 Contributes to HBV-related Hepatocellular Carcinoma Tumorigenesis
por: Wang, Qing, et al.
Publicado: (2020)

HBx Mediated Increase of DDX17 Contributes to HBV-Related Hepatocellular Carcinoma Tumorigenesis
por: Dong, Mei-Ling, et al.
Publicado: (2022)

The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation
por: Sartorius, Kurt, et al.
Publicado: (2021)

Immunohistochemical detection of aflatoxin B1-DNA adducts and hepatitis B virus antigens in hepatocellular carcinoma and nontumorous liver tissue.
por: Santella, R M, et al.
Publicado: (1993)

HBx mutants differentially affect the activation of hypoxia-inducible factor-1α in hepatocellular carcinoma
por: Liu, L-p, et al.
Publicado: (2014)

HBx regulates fatty acid oxidation to promote hepatocellular carcinoma survival during metabolic stress
por: Wang, Ming-Da, et al.
Publicado: (2016)

USP16 Downregulation by Carboxyl-terminal Truncated HBx Promotes the Growth of Hepatocellular Carcinoma Cells
por: Qian, Yu, et al.
Publicado: (2016)

The HBx–CTTN interaction promotes cell proliferation and migration of hepatocellular carcinoma via CREB1
por: Li, Yajun, et al.
Publicado: (2019)

HBx and c-MYC Cooperate to Induce URI1 Expression in HBV-Related Hepatocellular Carcinoma
por: Tsuchiya, Hiroyuki, et al.
Publicado: (2019)

HBx and YAP expression could promote tumor development and progression in HBV-related hepatocellular carcinoma
por: Oda, Chiyumi, et al.
Publicado: (2022)

Lack of colocalization of HBxAg and insulin like growth factor II in the livers of patients with chronic hepatitis B, cirrhosis and hepatocellular carcinoma.
por: Seo, J. H., et al.
Publicado: (1997)

Studies on the Efficacy, Potential Cardiotoxicity and Monkey Pharmacokinetics of GLP-26 as a Potent Hepatitis B Virus Capsid Assembly Modulator
por: Hurwitz, Selwyn J., et al.
Publicado: (2021)

Detecting Hepatitis B Surface Antigen Mutants
por: Coleman, Paul F.
Publicado: (2006)

OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets
por: Wong, David C. S., et al.
Publicado: (2023)

Targeting De Novo Lipogenesis and Cholesterol Biosynthesis Simultaneously is a Novel Therapeutic Option for Hepatocellular Carcinoma
por: Liu, Qian, et al.
Publicado: (2021)

Dendritic cells pulsed with Hsp70 and HBxAg induce specific antitumor immune responses in hepatitis B virus-associated hepatocellular carcinoma
por: WANG, HUI, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ut0e3j0p31skphqe1s1dmg1iok